Your browser doesn't support javascript.
loading
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.
Kunwar, Sandeep; Chang, Susan; Westphal, Manfred; Vogelbaum, Michael; Sampson, John; Barnett, Gene; Shaffrey, Mark; Ram, Zvi; Piepmeier, Joseph; Prados, Michael; Croteau, David; Pedain, Christoph; Leland, Pamela; Husain, Syed R; Joshi, Bharat H; Puri, Raj K.
Affiliation
  • Kunwar S; Division of Neuro-Oncology, Department of Neurological Surgery, University of California, 400 Parnassus Avenue, A-808, San Francisco, CA 94143-0350, USA. changs@neurosurg.ucsf.edu
Neuro Oncol ; 12(8): 871-81, 2010 Aug.
Article in En | MEDLINE | ID: mdl-20511192
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma / Interleukin-13 / Exotoxins / Neoplasm Recurrence, Local / Antineoplastic Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2010 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma / Interleukin-13 / Exotoxins / Neoplasm Recurrence, Local / Antineoplastic Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2010 Type: Article Affiliation country: United States